<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">IJCM</journal-id><journal-title-group><journal-title>International Journal of Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2158-284X</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ijcm.2021.1210037</article-id><article-id pub-id-type="publisher-id">IJCM-112380</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Large Vessel Vasculitis in a Patient with Systemic Lupus Erythematosus Presenting as Takayasu’s Pulseless Arteritis
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Cathy-Lee</surname><given-names>Jagdeo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Stephanie</surname><given-names>Battersby</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Azad</surname><given-names>Esack</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Neurology, The Eric Williams Medical Sciences Complex, Mt. Hope, Trinidad and Tobago</addr-line></aff><pub-date pub-type="epub"><day>09</day><month>10</month><year>2021</year></pub-date><volume>12</volume><issue>10</issue><fpage>415</fpage><lpage>423</lpage><history><date date-type="received"><day>21,</day>	<month>March</month>	<year>2021</year></date><date date-type="rev-recd"><day>8,</day>	<month>October</month>	<year>2021</year>	</date><date date-type="accepted"><day>11,</day>	<month>October</month>	<year>2021</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Systemic lupus erythematosus (SLE) with an associated aortoarteritis presenting as an ischemic stroke is a rarity in the medical literature. We report the case of an 11-year-old male presenting with an acute ischemic stroke meeting the criteria for the diagnosis of SLE and findings consistent with an aortitis on imaging but mimicking the diagnosis of Takayasu’s pulseless arteritis. Blood and imaging investigations revealed the finding of SLE aortitis following an acute stroke presentation. Thus, it is imperative to note that even though it is infrequent, SLE can be associated with a large vessel vasculitis.
 
</p></abstract><kwd-group><kwd>Systemic Lupus Erythematosus</kwd><kwd> Aortoarteritis</kwd><kwd> Takayasu’s Pulseless Arteritis</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>It is well recognized that the two common causes of large vessel arteritis are giant cell arteritis and Takayasu’s pulseless arteritis [<xref ref-type="bibr" rid="scirp.112380-ref1">1</xref>]. A less well known, cause is SLE especially SLE affecting the aorta and the great vessels arising from the aorta [<xref ref-type="bibr" rid="scirp.112380-ref2">2</xref>]. It is not uncommon for an ischaemic stroke to be caused by SLE but the pathophysiology usually involves vasculitis affecting smaller vessels and or increased stickiness of the blood itself [<xref ref-type="bibr" rid="scirp.112380-ref3">3</xref>].</p><p>There is a myriad of etiologies for stroke presentation in the younger population. Strokes in the pediatric groups of patients are relatively rare in which the reported incidence of strokes (ischemic and hemorrhagic) in children under 18 years old was reported to be 1.2 to 13 cases per 100,000 patients [<xref ref-type="bibr" rid="scirp.112380-ref4">4</xref>].</p><p>Etiologies of strokes range from cardio embolic phenomena, atherosclerosis and inflammatory diseases [<xref ref-type="bibr" rid="scirp.112380-ref5">5</xref>]. Vasculitis can lead to aneurysm formation or stenoses of the affected blood vessels which can result in limitation of blood flow to the brain resulting in stroke [<xref ref-type="bibr" rid="scirp.112380-ref6">6</xref>].</p><p>In this case report, the patient presented with an acute ischemic stroke in which the etiology was revealed as a lupus arteritis presentation with an associated large vessel vasculitis (aortitis); a rare occurrence as noted throughout the medical literature.</p></sec><sec id="s2"><title>2. Case Report</title><p>This is the clinical case report of an 11 year old Afro-Caribbean boy who presented with sudden onset of left upper limb and left lower limb weakness over a period of 2 days. The patient had a background history of a normocytic anaemia which was previously being investigated. Prior to this, there was one hospital admission 2 years ago when the patient presented with arthralgia and chest pain for which no definitive diagnosis was made at the time.</p><p>There were also complaints of facial twisting, slurred speech, intermittent diplopia and generalized headaches associated with two isolated episodes of fever.</p><p>On physical examination on admission, the boy was noted to have a BP 114/66 mmHg, a tachycardia of 117 beats per minute and he was tachypneic with a temperature of 37.9 degrees Celsius. His oxygen saturation on room air was 97% and his random blood glucose was recorded as 113 mg/dL. There was a grade 2/6 ejection systolic murmur noted in the aortic region with no radiation. Auscultation of the chest and abdominal examination were both unremarkable.</p><p>On neurological examination, his Glasgow coma scale score was 15/15 and the patient was oriented to time, person and place. Visual field testing revealed a left incongruous homonymous hemianopia. Fundoscopy was normal. A left upper motor facial weakness was present. Bulbar function and speech were normal.</p><p>On limb examination, tone was markedly reduced in the left upper and lower limbs. The power of the left upper and lower limb was 0/5, whilst the power of the right upper and lower limb was 5/5. The patient was hyperreflexic throughout with left ankle clonus and a left up going plantar response. There were no abnormal cerebellar or sensory findings and the gait could not be assessed.</p><p>Both radial and the right posterior tibial pulses were palpably absent.</p></sec><sec id="s3"><title>3. Results</title><p>CT brain without contrast revealed wedge shaped hypo densities in the right superior fronto-parietal region as shown below in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</p><p>On contrast administration, there was no enhancement of the lesions.</p><p>MRI/Angiogram brain demonstrated a large right cerebral infarct involving the right middle cerebral artery territory mainly, plus an absent right internal carotid artery and attenuation of the right middle cerebral artery (<xref ref-type="fig" rid="fig2">Figure 2</xref> and <xref ref-type="fig" rid="fig3">Figure 3</xref>).</p><p>CT angiogram showed a filling defect in the proximal right common carotid and abnormalities in the aortic arch consistent with inflammatory disease (<xref ref-type="fig" rid="fig4">Figure 4</xref> and <xref ref-type="fig" rid="fig5">Figure 5</xref>).</p><p>A normocytic normochromic anaemia was noted with a Hb 8.6 g/dL. There was no renal impairment with a Cr 1.0 and electrolytes all within normal limits. Liver function tests were within normal limits while the erythrocyte sedimentation rate (ESR) was &gt;125 mmhr<sup>−</sup><sup>1</sup> and C-reactive protein was elevated 242 mg/dL.</p><p>Fasting lipid profiles were as follows Total Cholesterol 146 mg/dL, TG 119 mg/dL, HDL 21 mg/dL, LDL 102 mg/dL and VLDL 24 mg/dL. Coagulation studies and thyroid function were within normal limits. Other significant investigations were as follows as shown in <xref ref-type="table" rid="table1">Table 1</xref>.</p><p>ECG showed normal sinus rhythm and transthoracic echocardiogram done on 2 separate occasions demonstrated a normal left ventricle and valves without any evidence of thrombus, vegetation or shunts.</p></sec><sec id="s4"><title>4. Management</title><p>Before the results of the autoimmune screen (ANA, dsDNA) were available, the initial thought was a diagnosis of Takayasu’s pulseless arteritis.</p><p>The patient was treated with methylprednisolone 1 g iv od for 3 days followed by high dose prednisolone on alternating days. He became drowsy whilst his ESR remained &gt; 125 mmHr<sup>−</sup><sup>1</sup> following steroid administration.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Blood investigations</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >HIV Rapid Test</th><th align="center" valign="middle" >Negative</th></tr></thead><tr><td align="center" valign="middle" >Hb Electrophoresis</td><td align="center" valign="middle" >A1 + A2</td></tr><tr><td align="center" valign="middle" >Sickle Cell Test</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >Urine Cocaine</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >Urine Marijuana</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >VDRL</td><td align="center" valign="middle" >Non reactive</td></tr><tr><td align="center" valign="middle" >Hb A1c</td><td align="center" valign="middle" >4.6%</td></tr><tr><td align="center" valign="middle" >HepBsAg</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >Anti-HCV</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >Rheumatoid Factor</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >Blood culture &#215; 4</td><td align="center" valign="middle" >NBG</td></tr><tr><td align="center" valign="middle" >Urine Culture</td><td align="center" valign="middle" >NBG</td></tr><tr><td align="center" valign="middle" >Urinalysis</td><td align="center" valign="middle" >NAD</td></tr><tr><td align="center" valign="middle" >ANA</td><td align="center" valign="middle" >Positive</td></tr><tr><td align="center" valign="middle" >Anti-dsDNA</td><td align="center" valign="middle" >67.19 (Positive)</td></tr><tr><td align="center" valign="middle" >ANF</td><td align="center" valign="middle" >126.85 (Positive)</td></tr><tr><td align="center" valign="middle" >Homocysteine</td><td align="center" valign="middle" >6.3 (normal)</td></tr><tr><td align="center" valign="middle" >pANCA</td><td align="center" valign="middle" >32.76 (elevated)</td></tr><tr><td align="center" valign="middle" >cANCA</td><td align="center" valign="middle" >63.83 (elevated)</td></tr><tr><td align="center" valign="middle" >Anti-thrombin</td><td align="center" valign="middle" >Not done</td></tr><tr><td align="center" valign="middle" >Protein C</td><td align="center" valign="middle" >122 (normal)</td></tr><tr><td align="center" valign="middle" >Protein S</td><td align="center" valign="middle" >6.9 (low)</td></tr><tr><td align="center" valign="middle" >Factor V leiden</td><td align="center" valign="middle" >2.21 (normal)</td></tr><tr><td align="center" valign="middle" >Anti-cardiolipin antibodies</td><td align="center" valign="middle" >negative</td></tr></tbody></table></table-wrap><p>Prednisolone was then switched to dexamethasone 4 mg iv tid. However, the boy looked distinctly unwell and his ESR still remained persistently elevated above 125 mmHr<sup>−</sup><sup>1</sup>.</p><p>There was a new complaint of visual blurring of the right eye. Fundoscopic examination revealed a pale retina and possibly early optic atrophy of the right eye (<xref ref-type="fig" rid="fig6">Figure 6</xref>).</p><p>Intravenous immunoglobulin (IVIG) (0.4 g/kg/day) was then administered for 5 days.</p><p>After a small number of days there was slow but steady improvement in the patient’s overall condition. Daily physiotherapy and stroke rehabilitation were instituted after which the patient was discharged on oral prednisolone and followed in the outpatient clinic.</p><p>Two weeks later the boy appeared better. His peripheral pulses returned and the ESR started to trend downward. One month later, he was walking with help but left arm function was still very much impaired. He remains on a reducing dose of oral prednisolone.</p></sec><sec id="s5"><title>5. Discussion</title><p>There is a paucity in the literature of reported cases demonstrating patients diagnosed with SLE having an associated large vessel vasculitis. The classic large vessel vasculitides include giant cell arteritis and Takayasu’s arteritis [<xref ref-type="bibr" rid="scirp.112380-ref1">1</xref>]. In one case report, there was an associated large vessel vasculopathy in a Japanese patient with a background diagnosis of SLE and temporal arteritis [<xref ref-type="bibr" rid="scirp.112380-ref7">7</xref>]. We found a similar case to ours where there was a patient with a Takayasu’s arteritis presentation followed by an associated diagnosis of SLE [<xref ref-type="bibr" rid="scirp.112380-ref8">8</xref>]. In this reported case, the patient was a 24 year old Indian female who initially presented with clinical symptoms and signs consistent with a diagnosis of Takayasu’s pulseless arteritis. Three years later she then represented with rash, arthralgia, non scarring alopecia and other clinical features of SLE [<xref ref-type="bibr" rid="scirp.112380-ref8">8</xref>]. In our case, the patient similarly presented originally with clinical features more consistent with a diagnosis of Takayasu’s pulseless arteritis but with a much more persistently elevated ESR. In</p><p>our patient, the diagnosis of SLE was made on the same admission and based on the previous complaints of arthralgia plus the positive autoimmune blood investigations.</p><p>Of note, there have been reported cases of non specific aortitis involving the aorta and its main branches with non specific symptomatology unfulfilling the diagnostic criteria for SLE [<xref ref-type="bibr" rid="scirp.112380-ref9">9</xref>]. Aortoarteritis is more prevalent in Japan and Afro-asian countries and has been noted to rarely be associated with SLE [<xref ref-type="bibr" rid="scirp.112380-ref10">10</xref>].</p><p>Another differential diagnosis worthy of mention includes a study by Wichremasinghe et al. [<xref ref-type="bibr" rid="scirp.112380-ref11">11</xref>]. They reported a small number of patients with emboligenic aortoarteritis where thrombi formation occurred from a transient form of focal aortoarteritis involving the medial elastic tissue of the aorta. This led to a potential etiology for an ischemic stroke in the younger population. None of their patients had a diagnosis of SLE. It is plausible that our patient could have had thromboembolism from inflammatory disease of the aorta and one of its main branches giving rise to the middle cerebral occlusion and possibly the right ophthalmic artery as well.</p><p>The boy presented with what appeared to be a good fit for the diagnosis of Takayasu’s pulseless arteritis. The absent pulses, involvement of the aorta and great vessels and raised ESR were well in keeping with this diagnosis [<xref ref-type="bibr" rid="scirp.112380-ref12">12</xref>]. However, Takayasu’s pulseless arteritis is seen primarily in Asian women and is not associated with lupus antibodies [<xref ref-type="bibr" rid="scirp.112380-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.112380-ref13">13</xref>]. Furthermore, there have not been any reported cases of Takayasu’s pulseless arteritis in the Caribbean population plus SLE is a relatively common disorder in people of Afro-Caribbean descent [<xref ref-type="bibr" rid="scirp.112380-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.112380-ref15">15</xref>]. Our patient met the criteria for the diagnosis of SLE based on the EULAR/ ACR scoring scale [<xref ref-type="bibr" rid="scirp.112380-ref16">16</xref>].</p></sec><sec id="s6"><title>6. Conclusion</title><p>Even though the occurrence of SLE associated with a large vessel vasculitis is an unusual occurrence in the medical literature, the incidence is important to note as it can impact on the outcome of patients’ morbidity and mortality.</p></sec><sec id="s7"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s8"><title>Cite this paper</title><p>Jagdeo, C.-L., Battersby, S. and Esack, A. (2021) Large Vessel Vasculitis in a Patient with Systemic Lupus Erythematosus Presenting as Takayasu’s Pulseless Arteritis. International Journal of Clinical Medicine, 12, 415-423. https://doi.org/10.4236/ijcm.2021.1210037</p></sec><sec id="s9"><title>Abbreviations</title><p>SLE: Systemic lupus erythematosus</p><p>ESR: Erythrocyte sedimentation rate</p></sec></body><back><ref-list><title>References</title><ref id="scirp.112380-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Gulati, A. and Bagga, A. (2010) Large Vessel Vasculitis. Pediatric Nephrology, 25, 1037-1048. https://doi.org/10.1007/s00467-009-1312-9</mixed-citation></ref><ref id="scirp.112380-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Irlapati, R.V.P., Sabella, A.R. and Rajasekhar, L. (2016) AB0503 Large Vessel Vasculitis in Systemic Lupus Erythematosus—A Case Series from a Single Centre in South India. Annals of the Rheumatic Diseases, 75, 1077-1078. https://doi.org/10.1136/annrheumdis-2016-eular.2642</mixed-citation></ref><ref id="scirp.112380-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Ioannidis, S., Mavridis, M. and Mitsias, P.D. (2018) Ischemic Stroke as Initial Manifestation of Systemic Lupus Erythematosus: A Case Report and Review of the Literature. eNeurologicalSci, 13, 26-30. https://doi.org/10.1016/j.ensci.2018.11.001</mixed-citation></ref><ref id="scirp.112380-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Tsze, D.S. and Valente, J.H. (2011) Pediatric Stroke: A Review. Emergency Medicine International, 2011, Article ID: 734506. https://doi.org/10.1155/2011/734506</mixed-citation></ref><ref id="scirp.112380-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Albers, G.W., Amarenco, P., Babikian, V.L., Biller, J., et al. (1997) Etiology of Stroke. Stroke, 28, 1501-1506.https://doi.org/10.1161/01.STR.28.7.1501</mixed-citation></ref><ref id="scirp.112380-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Aljanabi, N.M., Mamtani, S.S., Acharya, A., Gupta Rauniyar, R.P. and Malik, B.H. (2019) Association between Cerebrovascular Accident and Vasculitis: Myth or Reality? Cureus, 11, e6345. https://doi.org/10.7759/cureus.6345</mixed-citation></ref><ref id="scirp.112380-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Waki, D., Onishi, A. and Morinobu, A. (2019) Large Vessel Vasculopathy in a Patient with Systemic Lupus Erythematosus: A Case Report. Journal of Medical Case Reports, 13, Article No. 189. https://doi.org/10.1186/s13256-019-2126-4</mixed-citation></ref><ref id="scirp.112380-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Bandyopadhyay, D., Ganesan, V., Bhar, D., Bhowmick, D., Sasmal, S., Choudhury, C., et al. (2015) Takayasu’s Arteritis with Systemic Lupus Erythematosus: A Rare Association. Case Reports in Rheumatology, 2015, Article ID: 934196. https://doi.org/10.1155/2015/934196</mixed-citation></ref><ref id="scirp.112380-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Thenabadu, P.N., Rajasuriya, K. and Wickremasinghe, H.R. (1970) Non-Specific Arteritis of the Aorta and Its Main Branches. British Heart Journal, 32, 181-188. https://doi.org/10.1136/hrt.32.2.181</mixed-citation></ref><ref id="scirp.112380-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Chakrabarti, N. and Chattopadhyay, C. (2012) Aortoarteritis with Systemic Lupus Erythematosus and Secondary Antiphopholipid Syndrome. Indian Dermatology Online Journal, 3, 66-68. https://doi.org/10.4103/2229-5178.93483</mixed-citation></ref><ref id="scirp.112380-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Wickremasinghe, H.R., Peiris, J.B., Thenabadu, P.N. and Sheriffdeen, A.H. (1978) Transient Emboligenic Aortoarteritis Noteworthy New Entity in Young Stroke Patients. Archives of Neurology, 35, 416-422. https://doi.org/10.1001/archneur.1978.00500310018004</mixed-citation></ref><ref id="scirp.112380-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Johnston, S.L., Lock, R.J. and Gompels, M.M. (2002) Takayasu Arteritis: A Review. Journal of Clinical Pathology, 55, 481-486. https://doi.org/10.1136/jcp.55.7.481</mixed-citation></ref><ref id="scirp.112380-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Numano, F. (2002) The Story of Takayasu Arteritis. Rheumatology, 41, 103-106. https://doi.org/10.1093/rheumatology/41.1.103</mixed-citation></ref><ref id="scirp.112380-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Flower, C., Hennis, A.J.M., Hambleton, I.R., Nicholson, G.D., Liang, M.H. and Barbados National Lupus Registry Group (2012) Systemic Lupus Erythematosus in an African Caribbean Population: Incidence, Clinical Manifestations, and Survival in the Barbados National Lupus Registry. Arthritis Care &amp; Research, 64, 1151-1158. https://doi.org/10.1002/acr.21656</mixed-citation></ref><ref id="scirp.112380-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Cabas-Vargas, J., Patel, N.M., Cohen, J. and Ginzler, E.M. (2012) Sociodemographic Characteristics of SLE Patients in a Large Metropolitan Area with a High Afro-Carib-bean Population. Arthritis Research &amp; Therapy, 14, A49. https://doi.org/10.1186/ar3983</mixed-citation></ref><ref id="scirp.112380-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Aringer, M., Costenbader, K., Daikh, D., Brinks, R., Mosca, M., Ramsey-Goldman, R., et al. (2019) European League against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis &amp; Rheumatology, 71, 1400-1412.</mixed-citation></ref></ref-list></back></article>